Contact Us
The Center for Cancer Therapeutic Innovation (CCTI) conducts phase I clinical trials for many types of solid tumor cancers. Patients and referring physicians are welcome to contact us for more information about current phase I clinical trials for cancer.
If you are a patient interested in finding out more about phase I trials, please contact us using this secure online form, by calling 617-632-3332, via email at cctireferral@dfci.harvard.edu, or by fax at 617-632-2630.
If you are a physician interested in referring a patient to a phase I trial, please contact us using this secure online form, by calling 617-632-3332, via email at cctireferral@dfci.harvard.edu, or by fax at 617-632-2630.
CCTI New Patient Coordinator: cctireferral@dfci.harvard.edu
CCTI nursing contact: cctireferral@dfci.harvard.edu
Mailing Address
Center for Cancer Therapeutic Innovation
Dana-Farber Cancer Institute
450 Brookline Avenue, Yawkey 6
Boston, MA 02215